AlphaOne Investment Services’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-32,300
Closed -$1.07M 161
2019
Q2
$1.07M Sell
32,300
-5,813
-15% -$199K 0.83% 37
2019
Q1
$1.33M Sell
38,113
-43,728
-53% -$1.63M 0.8% 60
2018
Q4
$2.72M Sell
81,841
-10,728
-12% -$461K 1.12% 53
2018
Q3
$4.66M Sell
92,569
-33,710
-27% -$1.66M 1.38% 34
2018
Q2
$7.56M Sell
126,279
-16,015
-11% -$830K 2.17% 6
2018
Q1
$6.52M Sell
142,294
-25,578
-15% -$1.07M 1.79% 8
2017
Q4
$6.69M Buy
167,872
+1,060
+0.6% +$41.9K 2.02% 8
2017
Q3
$6.67M Sell
166,812
-53,125
-24% -$2.3M 1.77% 9
2017
Q2
$9.48M Sell
219,937
-7,500
-3% -$267K 2.55% 4
2017
Q1
$7.12M Buy
227,437
+19,781
+10% +$530K 1.79% 7
2016
Q4
$5.25M Sell
207,656
-3,200
-2% -$71.5K 1.45% 14
2016
Q3
$5.21M Sell
210,856
-20,811
-9% -$471K 1.71% 10
2016
Q2
$4.72M Sell
231,667
-16,250
-7% -$288K 1.74% 8
2016
Q1
$3.78M Buy
247,917
+7,874
+3% +$103K 1.55% 19
2015
Q4
$3.23M Buy
240,043
+4,978
+2% +$77K 1.15% 42
2015
Q3
$3.3M Sell
235,065
-187,446
-44% -$3.49M 1.4% 35
2015
Q2
$7.17M Sell
422,511
-136,450
-24% -$1.94M 2.52% 2
2015
Q1
$6.76M Buy
558,961
+87,050
+18% +$823K 2.54% 2
2014
Q4
$3.92M Buy
+471,911
New +$3.96M 1.46% 24

Other funds holding SUPN

AlphaOne Investment Services's SUPN Position: Q3 2019 in Review

AlphaOne Investment Services sold out of Supernus Pharmaceuticals (SUPN) in Q3 2019, closing a stake of 32,300 shares — an estimated $1.07M sold.

AlphaOne Investment Services first reported a position in SUPN in Q4 2014 and held it in 19 quarters. The position peaked at $9.48M in Q2 2017. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.

  • AlphaOne Investment Services reported no remaining Supernus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • AlphaOne Investment Services sold 32,300 Supernus Pharmaceuticals shares in Q3 2019, an estimated $1.07M.
  • AlphaOne Investment Services first reported a position in Supernus Pharmaceuticals in Q4 2014 and held it in 19 quarters.
  • AlphaOne Investment Services's Supernus Pharmaceuticals position peaked at $9.48M in Q2 2017.
  • 243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.

Based on AlphaOne Investment Services's 13F filing for Q3 2019, filed 12 Nov 2019.